Director of Pediatrix Medical Group, Inc. (NYSE:MD) sells $78,120.00 in stock

Pediatrix Medical Group, Inc. (NYSE:MD – Get Your Free Report) Director Laura A. Linynsky sold 7,000 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the transaction, the director now directly owns 30,805 shares in the company, valued at approximately $343,783.80. The transaction was disclosed in a filing with the SEC, which is available at this link.

Pediatrix Medical Group stock fell 1.5%

Shares of MD opened at $10.86 on Friday. The company’s 50-day moving average price is $8.67 and its 200-day moving average price is $8.63. Pediatrix Medical Group, Inc. it has a fifty-two week low of $6.62 and a fifty-two week high of $14.48. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.38, and a current ratio of 1.38.

Pediatrix Medical Group (NYSE:MD – Get Free Report ) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.03. The company had revenue of $504.30 million for the quarter, compared to the consensus estimate of $505.49 million. Pediatrix Medical Group had a negative net margin of 12.58% and a positive return on equity of 10.59%. The company’s quarterly revenue was up 0.7% compared to the same quarter last year. During the same period in the previous year, the firm posted EPS of $0.37. As a group, analysts estimate that Pediatrix Medical Group, Inc. will post 1.18 EPS for the current year.

Analyst upgrades and downgrades

A number of analysts have issued reports on MD shares. Truist Financial upped their target price on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. StockNews.com raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft raised shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price for the company in a research report on Friday, June 7th. Finally, UBS Group upped their price objective on Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a research report on Friday, August 9th. Six analysts have rated the stock with a hold rating. The company has a consensus rating of “Hold” and an average price target of $9.30, according to MarketBeat.com.

Read our latest MD review

Pediatrix Medical Group Institutional Marketing

A number of institutional investors have recently bought and sold shares of the company. Louisiana State Employees Retirement System purchased a new stake in Pediatrix Medical Group during the fourth quarter valued at approximately $385,000. Victory Capital Management Inc. raised its stake in Pediatrix Medical Group by 191.9% during the 4th quarter. Victory Capital Management Inc. now owns 118,131 shares of the company’s stock worth $1,099,000 after purchasing an additional 77,658 shares during the last quarter. M&T Bank Corp grew its position in Pediatrix Medical Group by 6.9% in the fourth quarter. M&T Bank Corp now owns 48,771 shares of the company’s stock valued at $453,000 after acquiring an additional 3,157 shares in the last quarter. LSV Asset Management boosted its stake in Pediatrix Medical Group by 108.9% in the fourth quarter. LSV Asset Management now owns 49,500 shares of the company’s stock valued at $460,000 after acquiring an additional 25,800 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock valued at $15,197,000 after purchasing an additional 148,600 shares during the last quarter. 97.71% of shares are held by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

(Get a free report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides neonatal, maternal-fetal, pediatric and other pediatric subspecialty care services in the United States. Provides neonatal care services, such as clinical care for infants born prematurely or with complications in certain hospital units through subspecialist neonatal physicians, neonatology nurses, and other pediatric clinicians.

Recommended articles

Get daily news and reviews for Pediatrix Medical Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Pediatrix Medical Group and related companies with MarketBeat.com’s FREE daily email newsletter.